Leticia Alle Deveza

Leticia Alle Deveza

Auto-generated profile, based on publicly available information

Leticia Alle Deveza

Sydney Musculoskeletal Health, Kolling Institute, University of Sydney, Sydney, NSW, Australia

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2017 in Osteoarthritis and Cartilage
Verified
Journal Article
Closed access
LDL.A. Deveza
L.A. Deveza
LML. Melo
L. Melo
TYT.P. Yamato
T.P. Yamato
KMK. Mills
K. Mills
VRV. Ravi
V. Ravi
DHDavid Hunter
David Hunter

15 December 2017 in Rheumatology
Verified
Journal Article
Closed access
PDF file
LDLeticia A Deveza
Leticia A Deveza
RLRichard F Loeser
Richard F Loeser
OA is a multifaceted and heterogeneous syndrome that may be amenable to tailored treatment. There has been an increasing focus within the OA research community on the identification of meaningful OA phenotypes with potential implications for prognosis and treatment. Experimental and clinical data combined with sophisticated statistical approaches have been used to characterize and define phenotypes from the symptomatic and structural perspectives. An improved understanding of the existing phenotypes based on underlying disease mechanisms may shed light on the distinct entities that make up the disease. This narrative review provides an updated summary of the most recent advances in this field as well as limitations from previous approaches that can be addressed in future studies.

1 January 2019
Verified
Journal Article
Closed access
LDL. A. Deveza
L. A. Deveza
ANA. E. Nelson
A. E. Nelson
RLR. F. Loeser
R. F. Loeser

3 May 2022 in Arthritis Care & Research
Verified
Journal Article
Closed access
PDF file
DHDavid Hunter
David Hunter
LDLeticia A. Deveza
Leticia A. Deveza
JCJamie Elizabeth Collins
Jamie Elizabeth Collins
ELElena Losina
Elena Losina
JKJeffrey N. Katz
Jeffrey N. Katz
VKVirginia B. Kraus
Virginia B. Kraus

20 March 2020 in Arthritis Research & Therapy
Verified
Journal Article
Open access
PDF file
ESErwin (W.E.) Van Spil
Erwin (W.E.) Van Spil
SBS. M. A. Bierma-Zeinstra
S. M. A. Bierma-Zeinstra
LDL. A. Deveza
L. A. Deveza
NAN. K. Arden
N. K. Arden
AJAnne-Christine Bay Jensen
Anne-Christine Bay Jensen
DHDavid Hunter
David Hunter
Background: The concept of osteoarthritis (OA) heterogeneity is evolving and gaining renewed interest. According to this concept, distinct subtypes of OA need to be defined that will likely require recognition in research design and different approaches to clinical management. Although seemingly plausible, a wide range of views exist on how best to operationalize this concept. The current project aimed to provide consensus-based definitions and recommendations that together create a framework for conducting and reporting OA phenotype research. Methods: A panel of 25 members with expertise in OA phenotype research was composed. First, panel members participated in an online Delphi exercise to provide a number of basic definitions and statements relating to OA phenotypes and OA phenotype research. Second, panel members provided input on a set of recommendations for reporting on OA phenotype studies. Results: Four Delphi rounds were required to achieve sufficient agreement on 11 definitions and statements. OA phenotypes were defined as subtypes of OA that share distinct underlying pathobiological and pain mechanisms and their structural and functional consequences. Reporting recommendations pertaining to the study characteristics, study population, data collection, statistical analysis, and appraisal of OA phenotype studies were provided. Conclusions: This study provides a number of consensus-based definitions and recommendations relating to OA phenotypes. The resulting framework is intended to facilitate research on OA phenotypes and increase combined efforts to develop effective OA phenotype classification. Success in this endeavor will hopefully translate into more effective, differentiated OA management that will benefit a multitude of OA patients.

23 March 2023 in Osteoarthritis and Cartilage
Verified
Journal Article
Closed access
NFN.E. Foster
N.E. Foster
LEL. Eriksson
L. Eriksson
LDL. Deveza
L. Deveza
MHM. Hall
M. Hall